Key takeaways
- New research explores the role of vasoactive intestinal peptide (VIP) in immunometabolism and neuroinflammation.
- A case report describes a patient with a rare tumor secreting VIP.
- There are no new human trials on 5-amino-1mq, a small molecule that blocks the NNMT enzyme.
Recent studies have shed more light on the functions of Vasoactive Intestinal Peptide (VIP) and its potential therapeutic applications. VIP is a natural hormone that relaxes blood vessels and calms inflammation. Researchers have identified VIP as a key regulator of immunometabolism and neuroinflammation, influencing macrophage polarization, T cell differentiation, and cytokine production 1.
A case report published in Endocrinology, Diabetes & Metabolism Case Reports describes a patient with a rare tumor that secreted VIP, causing chronic diarrhea and hyponatremia 2. This report highlights the importance of considering VIP in the diagnosis of patients with unexplained gastrointestinal symptoms.
On the other hand, there are no new human trials on 5-Amino-1MQ, a small molecule that blocks the NNMT enzyme. While previous studies have shown that 5-Amino-1MQ can reduce body weight and fat-cell size in mice, its effects in humans remain unknown.
vip and immunometabolism
VIP has been shown to play a crucial role in regulating immunometabolism and neuroinflammation 1. It influences the production of cytokines and the polarization of macrophages, which can contribute to the development of chronic diseases such as obesity and diabetes. Further research is needed to fully understand the mechanisms by which VIP exerts its effects and to explore its potential therapeutic applications.
5-amino-1mq and nnmt inhibition
5-Amino-1MQ is a small molecule that inhibits the NNMT enzyme, which is involved in the regulation of fat metabolism. While it has shown promise in reducing body weight and fat-cell size in mice, its effects in humans remain unknown due to the lack of published human trials. More research is needed to determine the safety and efficacy of 5-Amino-1MQ in humans.
{{5-amino-1mq}}
comparison of vip and 5-amino-1mq
| What it is | FDA status | Evidence (1–5) | Half-life | Banned in sport |
|---|---|---|---|---|
| VIP | Not FDA-approved | 3 | 2 minutes | No |
| 5-Amino-1MQ | Not FDA-approved | 2 | Not established | Yes |
the bottom line
New research highlights the importance of VIP in regulating immunometabolism and neuroinflammation, while 5-Amino-1MQ remains a promising but untested compound in humans. Further studies are needed to fully understand the mechanisms and potential therapeutic applications of these compounds.
This is educational information, not medical advice.
Sources
- Neuropeptides in Immunometabolism and Neuroinflammation: Insights from Traditional Chinese Medicine — Neuroendocrinology, 2026/10/12
- Composite pheochromocytoma-ganglioneuroma secreting vasoactive intestinal peptide — Endocrinology, diabetes & metabolism case reports, 2026/10/01
